STAT-3 activation by differential cytokines is critical for human in vivo-generated plasma cell survival and Ig secretion

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 4996-5004

  Rodríguez Bayona, Beatriz ^a   Ramos Amaya, Ana ^a   López Blanco, Rubén ^a   Campos Caro, Antonio ^a   Brieva, Jose A ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 21; INTERLEUKIN 6; SOMATOMEDIN C; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; IMMUNOGLOBULIN; INTERLEUKIN DERIVATIVE; MESSENGER RNA; STAT3 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1; TNFSF13B PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANTIBODY PRODUCTION; ARTICLE; BLOOD; BONE MARROW; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IN VIVO STUDY; LYMPHOID ORGAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; B LYMPHOCYTE; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION;

B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CXCL12; ENZYME ACTIVATION; HUMANS; IMMUNOGLOBULINS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKINS; LYMPHOCYTE ACTIVATION; PHOSPHORYLATION; PLASMA CELLS; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84887431252     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301559     Document Type: Article

References (51)

1. Liu, Y. J., J. Zhang, P. J. Lane, E. Y. Chan, and I. C. MacLennan. 1991. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21:2951-2962.
2. Smith, K. G., T. D. Hewitson, G. J. Nossal, and D. M. Tarlinton. 1996. The phenotype and fate of the antibody-forming cells of the splenic foci. Eur. J. Immunol. 26:444-448.
3. Manz, R. A., A. Thiel, and A. Radbruch. 1997. Lifetime of plasma cells in the bone marrow. Nature 388:133-134.
4. Smith, K. G., A. Light, G. J. Nossal, and D. M. Tarlinton. 1997. The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J. 16:2996-3006.
5. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363-372.
6. Kallies, A., J. Hasbold, D. M. Tarlinton, W. Dietrich, L. M. Corcoran, P. D. Hodgkin, and S. L. Nutt. 2004. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J. Exp. Med. 200:967-977.
7. Blink, E. J., A. Light, A. Kallies, S. L. Nutt, P. D. Hodgkin, and D. M. Tarlinton. 2005. Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J. Exp. Med. 201:545-554.
8. Benner, R., W. Hijmans, and J. J. Haaijman. 1981. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin. Exp. Immunol. 46:1-8.
9. Hibi, T., and H. M. Dosch. 1986. Limiting dilution analysis of the B cell compartment in human bone marrow. Eur. J. Immunol. 16:139-145.
10. Roldán, E., A. Garćia-Pardo, and J. A. Brieva. 1992. VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion. J. Exp. Med. 175:1739-1747.
11. Brieva, J. A., E. Roldán, C. Rodríguez, and G. Navas. 1994. Human tonsil, blood and bone marrow in vivo-induced B cells capable of spontaneous and high-rate immunoglobulin secretion in vitro: differences in the requirements for factors and for adherent and bone marrow stromal cells, as well as distinctive adhesion molecule expression. Eur. J. Immunol. 24:362-366.
12. Merville, P., J. Déchanet, A. Desmoulière, I. Durand, O. De Bouteiller, P. Garrone, J. Banchereau, and Y. J. Liu. 1996. Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 183:227-236.
13. Medina, F., C. Segundo, C. Rodríguez, and J. A. Brieva. 1997. Regulatory role of CD95 ligation on human B cells induced in vivo capable of spontaneous and high-rate Ig secretion. Eur. J. Immunol. 27:700-706.
14. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-2202.
15. Odendahl, M., H. Mei, B. F. Hoyer, A. M. Jacobi, A. Hansen, G. Muehlinghaus, C. Berek, F. Hiepe, R. Manz, A. Radbruch, and T. Dörner. 2005. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105:1614-1621.
16. González-García, I., E. Ocaña, G. Jiménez-Gómez, A. Campos-Caro, and J. A. Brieva. 2006. Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells. J. Immunol. 176:4042-4050.
17. Medina, F., C. Segundo, A. Campos-Caro, I. González-García, and J. A. Brieva. 2002. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 99:2154-2161.
18. Zhan, F., E. Tian, K. Bumm, R. Smith, B. Barlogie, and J. Shaughnessy, Jr. 2003. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood 101:1128-1140.
19. De Vos, J., D. Hose, T. Rème, K. Tarte, J. Moreaux, K. Mahtouk, M. Jourdan, H. Goldschmidt, J. F. Rossi, F. W. Cremer, and B. Klein. 2006. Microarray-based understanding of normal and malignant plasma cells. Immunol. Rev. 210:86-104.
20. Jiménez-Gómez, G., J. L. Gómez-Perales, A. Ramos-Amaya, I. González-García, A. Campos-Caro, and J. A. Brieva. 2010. Modulated selection of IGHV gene somatic hypermutation during systemic maturation of human plasma cells. J. Leukoc. Biol. 87:523-530.
21. Sze, D. M., K. M. Toellner, C. García De Vinuesa, D. R. Taylor, and I. C. MacLennan. 2000. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192:813-821.
22. Ellyard, J. I., D. T. Avery, T. G. Phan, N. J. Hare, P. D. Hodgkin, and S. G. Tangye. 2004. Antigen-selected, immunoglobulin-secreting cells persist in human spleen and bone marrow. Blood 103:3805-3812.
23. Withers, D. R., C. Fiorini, R. T. Fischer, R. Ettinger, P. E. Lipsky, and A. C. Grammer. 2007. T cell-dependent survival of CD20+ and CD20-plasma cells in human secondary lymphoid tissue. Blood 109:4856-4864.
24. Winter, O., C. Dame, F. Jundt, and F. Hiepe. 2012. Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy. J. Immunol. 189:5105-5111.
25. Diehl, S. A., H. Schmidlin, M. Nagasawa, S. D. Van Haren, M. J. Kwakkenbos, E. Yasuda, T. Beaumont, F. A. Scheeren, and H. Spits. 2008. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J. Immunol. 180:4805-4815.
26. Kwon, H., D. Thierry-Mieg, J. Thierry-Mieg, H. P. Kim, J. Oh, C. Tunyaplin, S. Carotta, C. E. Donovan, M. L. Goldman, P. Tailor, et al. 2009. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31:941-952.
27. Avery, D. T., E. K. Deenick, C. S. Ma, S. Suryani, N. Simpson, G. Y. Chew, T. D. Chan, U. Palendira, J. Bustamante, S. Boisson-Dupuis, et al. 2010. B cellintrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207:155-171.
28. Fornek, J. L., L. T. Tygrett, T. J. Waldschmidt, V. Poli, R. C. Rickert, and G. S. Kansas. 2006. Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells. Blood 107:1085-1091.
29. González-García, I., B. Rodríguez-Bayona, F. Mora-López, A. Campos-Caro, and J. A. Brieva. 2008. Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies. Blood 111:741-749.
30. Amanna, I. J., and M. K. Slifka. 2010. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol. Rev. 236:125-138.
31. Chu, V. T., and C. Berek. 2013. The establishment of the plasma cell survival niche in the bone marrow. Immunol. Rev. 251:177-188.
32. Rodriguez-Bayona, B., A. Ramos-Amaya, J. Bernal, A. Campos-Caro, and J. A. Brieva. 2012. Cutting edge: IL-21 derived from human follicular helper T cells acts as a survival factor for secondary lymphoid organ, but not for bone marrow, plasma cells. J. Immunol. 188:1578-1581.
33. Arpin, C., J. Déchanet, C. Van Kooten, P. Merville, G. Grouard, F. Brière, J. Banchereau, and Y. J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science 268:720-722.
34. Minges Wols, H. A., G. H. Underhill, G. S. Kansas, and P. L. Witte. 2002. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 169:4213-4221.
35. Cassese, G., S. Arce, A. E. Hauser, K. Lehnert, B. Moewes, M. Mostarac, G. Muehlinghaus, M. Szyska, A. Radbruch, and R. A. Manz. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171:1684-1690.
36. Calame, K. 2008. Activation-dependent induction of Blimp-1. Curr. Opin. Immunol. 20:259-264.
37. Roldán, E., C. Rodriguez, G. Navas, C. Parra, and J. A. Brieva. 1992. Cytokine network regulating terminal maturation of human bone marrow B cells capable of spontaneous and high rate Ig secretion in vitro. J. Immunol. 149:2367-2371.
38. Peters, M., S. Jacobs, M. Ehlers, P. Vollmer, J. Müllberg, E. Wolf, G. Brem, K. H. Meyer Zum Büschenfelde, and S. Rose-John. 1996. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183:1399-1406.
39. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180:5771-5777.
40. Mallison, S. M., III, J. P. Smith, H. A. Schenkein, and J. G. Tew. 1991. Accumulation of plasma cells in inflamed sites: effects of antigen, nonspecific microbial activators, and chronic inflammation. Infect. Immun. 59:4019-4025.
41. Fairfax, K. C., E. Amiel, I. L. King, T. C. Freitas, M. Mohrs, and E. J. Pearce. 2012. IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease. PLoS Pathog. 8:e1002490.
42. Rozanski, C. H., R. Arens, L. M. Carlson, J. Nair, L. H. Boise, A. A. Chanan-Khan, S. P. Schoenberger, and K. P. Lee. 2011. Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells. J. Exp. Med. 208:1435-1446.
43. Bryant, V. L., C. S. Ma, D. T. Avery, Y. Li, K. L. Good, L. M. Corcoran, R. De Waal Malefyt, and S. G. Tangye. 2007. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179:8180-8190.
44. Fazilleau, N., L. Mark, L. J. McHeyzer-Williams, and M. G. McHeyzer-Williams. 2009. Follicular helper T cells: lineage and location. Immunity 30:324-335.
45. Morita, R., N. Schmitt, S. E. Bentebibel, R. Ranganathan, L. Bourdery, G. Zurawski, E. Foucat, M. Dullaers, S. Oh, N. Sabzghabaei, et al. 2011. Human blood CXCR5 (+) CD4 (+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34:108-121.
46. Tarlinton, D., A. Radbruch, F. Hiepe, and T. Dörner. 2008. Plasma cell differentiation and survival. Curr. Opin. Immunol. 20:162-169.
47. Mesin, L., R. Di Niro, K. M. Thompson, K. E. Lundin, and L. M. Sollid. 2011. Long-lived plasma cells from human small intestine biopsies secrete immunoglobulins for many weeks in vitro. J. Immunol. 187:2867-2874.
48. O'Connor, B. P., V. S. Raman, L. D. Erickson, W. J. Cook, L. K. Weaver, C. Ahonen, L. L. Lin, G. T. Mantchev, R. J. Bram, and R. J. Noelle. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199:91-98.
49. Peperzak, V., I. Vikström, J. Walker, S. P. Glaser, M. Le Page, C. M. Coquery, L. D. Erickson, K. Fairfax, F. Mackay, A. Strasser, et al. 2013. Mcl-1 is essential for the survival of plasma cells. Nat. Immunol. 14:290-297.
50. Vahedi, G., H. Takahashi, S. Nakayamada, H. W. Sun, V. Sartorelli, Y. Kanno, and J. J. O'Shea. 2012. STATs shape the active enhancer landscape of T cell populations. Cell 151:981-993.
51. Quintás-Cardama, A., H. Kantarjian, J. Cortes, and S. Verstovsek. 2011. Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond. Nat. Rev. Drug Discov. 10:127-140.